# Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease

> **NCT01099332** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Adeona Pharmaceuticals** · enrollment: 60 (estimated)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **OTHER:** Gastro-retentive zinc cysteine tablet
- **OTHER:** Tablet identical physically to active comparator containing some lactose

## Key facts

- **NCT ID:** NCT01099332
- **Lead sponsor:** Adeona Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099332, "Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01099332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*